Clinical Trial Update: PET Guided Dose Reduction for InvOlved Site Radiotherapy In Early sTage Unfavourable Hodgkin Lymphoma [Phase 3]

View source ↗

Summary

This clinical trial update describes an ongoing Phase 3 study evaluating PET-guided dose reduction for involved-site radiotherapy in early-stage unfavourable Ho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Snippet

Sponsor: Fondazione Italiana Linfomi - ETS | Conditions: Hodgkin Lymphoma | Phase 3 | Status: NOT_YET_RECRUITING